In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
no speaker photo
Speaker
Sigrun Halvorsen
Sigrun Halvorsen Sigrun Halvorsen

Oslo University Hospital Ulleval, Oslo (Norway)

Specialities : Acute Coronary Syndromes , Atrial Fibrillation, Pharmacology and Pharmacotherapy, Cardio-Oncology, Cardiovascular Disease in Women

Professor and Head of Department of Cardiology, Oslo University Hospital Ullevål, Norway

28 presentations from this speaker

High-risk ACS patient: select early the long-term treatment! - Take home message.

Event : Acute Cardiovascular Care 2019

  • Session : Long term treatment: the importance of getting it right first time!
  • Speaker : S Halvorsen (Oslo,NO)

Optimising NOAC management in atrial fibrilllation and ACS/PCI - Clinical practice perspective

Event : ESC Congress 2019

  • Session : Optimising non-vitamin K antagonist oral anticoagulant (NOAC) management in atrial fibrillation and acute coronary syndrome (ACS)/percutaneous coronary intervention (PCI) - Clinical practice perspective
  • Speaker : RF Storey (Sheffield,GB), R Lopes (Durham,US), S Halvorsen (Oslo,NO)
  • Sponsored by The Bristol-Myers Squibb/Pfizer Alliance

Anticoagulation alone is adequate treatment for intermediate-risk pulmonary embolism

Event : Acute Cardiovascular Care 2018

  • Session : To lyse or not to lyse the thrombus?
  • Speaker : S Halvorsen (Oslo,NO)

Atrial fibrillation patients who develop acute coronary syndrome: Is there a role for aspirin?

Event : ESC Congress 2018

  • Session : Atrial fibrillation patients who develop acute coronary syndrome: is there a role for aspirin?
  • Speaker : R Lopes (Durham,US), S Windecker (Bern,CH), S Halvorsen (Oslo,NO)
  • Sponsored by Bristol-Myers Squibb and Pfizer Alliance

Discussant review - The effect of randomization to aspirin in ASCEND.

Event : ESC Congress 2018

  • Session : Hot Line Session 2
  • Speaker : S Halvorsen (Oslo,NO)

Expect the unexpected – dealing with rare causes of cardiogenic shock.

Event : ESC Congress 2018

  • Session : Expert Advice - Cardiogenic shock during an ICU night shift – preparing for the worst to get the best
  • Speaker : S Halvorsen (Oslo,NO)

Fibrinolysis: when and how?

Event : Acute Cardiovascular Care 2018

  • Session : Pre-hospital ACS: diagnosis and treatments
  • Speaker : S Halvorsen (Oslo,NO)

Incidence, prevalence and survival in heart failure: a nationwide registry study from 2011-2016

Event : ESC Congress 2018

  • Session : Chronic heart failure – Epidemiology, prognosis, outcome
  • Speaker : S Halvorsen (Oslo,NO)

Post MI secondary prevention, getting it right first time - Challenges & discussion

Event : Acute Cardiovascular Care 2018

  • Session : Multi-disciplinary care in acute cardiovascular disease: what have I missed?
  • Speaker : S Halvorsen (Oslo,NO)

Preventing strokes in high risk AF patients: a practical approach.

Event : EHRA 2018

  • Session : Preventing strokes in high risk Atrial Fibrillation (AF) patients: a practical approach
  • Speaker : M Wehling (Mannheim,DE), S Halvorsen (Oslo,NO), R Collins (Dublin,IE)
  • Sponsored by BMS Pfizer

"Plaque but no obstructive coronary disease" - Primary or secondary prevention?

Event : ESC Congress 2017

  • Session : The Primary Prevention Summit
  • Speaker : S Halvorsen (Oslo,NO)

Barriers to risk factor control and adherence to medical therapy after an ACS.

Event : Webinar 2017

  • Session : ACVC Webinars 2017
  • Speaker : S Halvorsen (Oslo,NO), K Kotseva (London,GB), G Tavazzi (Pavia,IT)

Management of bleeding and other emergent situations in patients on NOACS in the acute setting - The role of antidotes.

Event : Webinar 2017

  • Session : ACVC Webinars 2017
  • Speaker : S Halvorsen (Oslo,NO), C Held (Uppsala,SE), A Niessner (Vienna,AT)

Primary PCI and fibrinolysis procedures.

Event : ESC Congress 2017

  • Session : ESC Guidelines 2017 - AMI-STEMI
  • Speaker : S Halvorsen (Oslo,NO)

The patient in focus: the fragile atrial fibrillation (AF) patient.

Event : ESC Congress 2017

  • Session : Expanding our knowledge of NOACs in SPAF: from evidence to enhanced patient outcomes
  • Speaker : S Halvorsen (Oslo,NO)
  • Sponsored by Bristol-Myers Squibb and Pfizer Alliance

Anti thrombotic choices after bleeding.

Event : Acute Cardiovascular Care 2016

  • Session : Dilemmas in anti thrombotic therapy
  • Speaker : S Halvorsen (Oslo,NO)
  • Joint session with the ESC Working Group on Thrombosis - This session is supported by an unrestricted educational grant from AstraZeneca

How to individualise therapy to prevent bleeds

Event : ESC Congress 2016

  • Session : Personalised antiplatelet therapy
  • Speaker : S Halvorsen (Oslo,NO)

Resumption of oral antithrombotics

Event : ESC Congress 2016

  • Session : Bridging of antithrombotic therapy for invasive procedure
  • Speaker : S Halvorsen (Oslo,NO)

Tailoring oral anticoagulation strategies in atrial fibrillation: spotlight on renally impaired and elderly patients.

Event : ESC Congress 2016

  • Session : Tailoring oral anticoagulation strategies in atrial fibrillation: spotlight on renally impaired and elderly patients
  • Speaker : S Hohnloser (Koenigstein,DE), S Halvorsen (Oslo,NO), CB Granger (Durham,US)
  • Sponsored by Bristol-Myers Squibb and Pfizer Alliance

Antithrombotics and anticoagulants.

Event : ESC Congress 2015

  • Session : Important drug interactions: what the cardiologist should know
  • Speaker : S Halvorsen (Oslo,NO)

ESC Guidelines to resolve dilemmas in clinical cardiology - Introduction to the session.

Event : ESC Congress 2015

  • Session : ESC Guidelines to resolve dilemmas in clinical cardiology
  • Speaker : S Halvorsen (Oslo,NO)

Incidence of bleeding and outcomes in acute coronary syndromes.

Event : ESC Congress 2015

  • Session : Patients with acute coronary syndromes: bleeding and blood transfusion
  • Speaker : S Halvorsen (Oslo,NO)

STEMI networks: a European perspective

Event : Acute Cardiovascular Care 2015

  • Session : Pre-hospital management of ACS
  • Speaker : S Halvorsen (Oslo,NO)

Novel oral anticoagulants or warfarin in the elderly - what is the best option?

Event : ESC Congress 2014

  • Session : Update on stroke prevention in atrial fibrillation
  • Speaker : S Halvorsen (Oslo,NO)

Which patients should be treated by a pharmaco-invasive strategy?

Event : ESC Congress 2014

  • Session : Challenges in antithrombotic treatment of STEMI
  • Speaker : S Halvorsen (Oslo,NO)

Management in percutaneous coronary and electrophysiological intervention.

Event : ESC Congress 2013

  • Session : New oral anticoagulants - clinical challenges
  • Speaker : S Halvorsen (Oslo,NO)

Members get more

Join now
  • 1ESC Professional Members – access all resources from general ESC events 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are